Answer
Although the interaction has not been studied, Zepatier’s elbasvir component may increase dabigatran concentrations through P-gp inhibition, potentially increasing bleeding risk, so clinical and laboratory monitoring is recommended.
Sources for this answer
- ZEPATIER 50 mg/100 mg film coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 13Document updated
Sources checked